Ocrevus and Cholestyramine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ocrevus (ocrelizumab) and Cholestyramine (cholestyramine). Common drug interactions include back pain among females and chest discomfort among males.

The phase IV clinical study analyzes what interactions people have when they take Ocrevus and Cholestyramine. It is created by eHealthMe based on reports of 41 people who take the same drugs from the FDA, and is updated regularly.

What is Ocrevus?

Ocrevus has active ingredients of ocrelizumab. eHealthMe is studying from 56,583 Ocrevus users. Check the latest studies of Ocrevus.

What is Cholestyramine?

Cholestyramine has active ingredients of cholestyramine. It is often used in diarrhea. eHealthMe is studying from 9,893 Cholestyramine users. Check the latest studies of Cholestyramine.

On Jul, 06, 2026

41 people who take Ocrevus and Cholestyramine together, and have interactions are studied.

Ocrevus and Cholestyramine drug interactions.

What are the common drug interactions of Ocrevus and Cholestyramine, by gender? *:

female:

Back pain
Blood glucose decreased
Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
Colitis microscopic (inflammation of colon with diarrhoea and abdominal cramps)
Colitis ulcerative (inflammation of colon with ulcer)
Decreased appetite
Depressed mood
Disease recurrence
Dysaesthesia (abnormal sensation)
Dyspepsia (indigestion)

male:

Chest discomfort
Balance disorder
Dizziness
Dysphagia (a condition in which swallowing is difficult or painful)
Dysphonia (speech disorder attributable to a disorder of phonation)
Fatigue (feeling of tiredness)
Feeling cold
Headache (pain in head)
Hypersensitivity
Hypothermia (body temperature drops below the required temperature for normal metabolism and body functions)

What are the common drug interactions of Ocrevus and Cholestyramine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Infusion related reaction
Muscle spasms (muscle contraction)
Optic neuritis (optic nerve inflammation)
Hysterectomy
Tubo-ovarian abscess (an abscess that involves the fallopian tube and corresponding ovary that is usually associated with inflammation of the fallopian tube)

40-49:

n/a

50-59:

Blood glucose decreased
Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
Colitis microscopic (inflammation of colon with diarrhoea and abdominal cramps)
Colitis ulcerative (inflammation of colon with ulcer)
Decreased appetite
Depressed mood
Disease recurrence
Dysaesthesia (abnormal sensation)
Dyspepsia (indigestion)
Grip strength decreased

60+:

Fatigue (feeling of tiredness)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Contusion (a type of hematoma of tissue in which capillaries)
Dizziness
Pain
Sensory disturbance (sense disturbance)
Anaemia (lack of blood)
Blood glucose increased
Cardiac failure congestive
Productive cough

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 12 people, 29.27%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 9 people, 21.95%
Primary Progressive Multiple Sclerosis (primary progressive inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 9 people, 21.95%
High Blood Cholesterol: 8 people, 19.51%
Stress And Anxiety: 7 people, 17.07%
Muscle Strain (an injury to a muscle in which the muscle fibres tear): 6 people, 14.63%
Back Pain: 5 people, 12.20%
Gastric Disorder (disease of stomach): 5 people, 12.20%
Indigestion: 5 people, 12.20%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 5 people, 12.20%

* Approximation only. Some reports may have incomplete information.

Do you take Ocrevus and Cholestyramine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously